Molecular and Advanced Pathology Core:
Bringing Spatial “Omics” From Glass to Clinic
The Molecular and Advanced Pathology Core, established in 2021, aims to bridge the life sciences at UBC with clinical expertise at Vancouver General Hospital and BC Cancer to advance the translation of discoveries to improve prevention and treatment of diseases across the population. Using multiplex Opal immunofluorescence from Akoya and new GeoMx Digital Spatial Profiling from Nanostring technologies, MAPcore is committed to furthering the success of omics and other discovery research by translating these finding to clinical utility.
MAPcore is an affiliated core facility with University of British Columbia Department of Pathology & Laboratory Medicine, Vancouver Coastal Health Research Institute, and BC Cancer Research Institute.